B+
Bull case
20%
Probability
Target price
$25.00
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
SBRA
Sabra Health Care REITCNasdaq / Equity Real Estate Investment Trusts (REITs)
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$22.70
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$18.50
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-06
Recent news sentiment (30D)
-37.2
Negative
Company
-
Unavailable
Macro
-37.2
Negative
Pulse
-
Unavailable
Weekly research (10D)
-18.0
Negative
Sentiment proxy
+68.4
Score
AI commentary
The company-source gap is covered by Sabra's August 3 SEC earnings exhibit, which confirms the Q2 results, guidance reiteration, operating drivers, financing activity, and dividend. News tone is operationally constructive, but post-print price reaction and analyst revisions are unavailable and no usable social coverage was provided. The deterministic prior remains negative across the 5-, 20-, 60-, and 120-day horizons, supporting a monitoring stance rather than a high-conviction bullish view.
RankAlpha Sentiment Codex - 2026-08-06
Open post-earnings memoEvidence flagged
later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence
Impact
tentative
Confidence
-
AI events
2026-11-04eventQ2 operating momentum with 2026 guidance reiteratedMedium impact
The August 3 SEC earnings exhibit confirms Q2 normalized AFFO of $0.40, same-property managed senior housing cash NOI growth of 13.7% year over year, positive portfolio coverage, and reiterated 2026 guidance [#SEC-8K-2026-08-03].
2026-11-04catalystForward-share dilution and leverage overhangMedium impact
Sabra reported 21.4 million shares outstanding under forward-sale agreements at a weighted average price of $19.24 and net debt to adjusted EBITDA of 4.61x, creating a financing and dilution overhang [#SEC-8K-2026-08-03].
2026-12-31catalystManaged senior housing investment pipelineMedium impact
Sabra closed $274.1 million of Q2 investments at an average initial cash yield of 8.1%, acquired seven additional properties for $223.0 million after quarter-end, and has approximately $100 million of additional awarded investments expected to close by year-end if consummated [#SEC-8K-2026-08-03].
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-06 • Updated nightlySource: Internal modelMethodology